281
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Cord blood oxidative stress markers correlate with umbilical artery pulsatility in fetal growth restriction

, , , &
Pages 576-580 | Received 20 Dec 2011, Accepted 23 Oct 2012, Published online: 29 Nov 2012

References

  • Hoffman C, Galan HL. Assessing the ‘at-risk’ fetus: Doppler ultrasound. Curr Opin Obstet Gynecol 2009;21:161–166.
  • Hecher K, Bilardo CM, Stigter RH, Ville Y, Hackelöer BJ, Kok HJ, Senat MV, Visser GH. Monitoring of fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet Gynecol 2001;18:564–570.
  • Ferrazzi E, Bozzo M, Rigano S, Bellotti M, Morabito A, Pardi G, Battaglia FC, Galan HL. Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol 2002;19:140–146.
  • Baschat AA. Doppler application in the delivery timing of the preterm growth-restricted fetus: another step in the right direction. Ultrasound Obstet Gynecol 2004;23:111–118.
  • Toy H, Camuzcuoglu H, Arioz DT, Kurt S, Celik H, Aksoy N. Serum prolidase activity and oxidative stress markers in pregnancies with intrauterine growth restricted infants. J Obstet Gynaecol Res 2009;35:1047–1053.
  • Caldas JP, Vilela MM, Braghini CA, Mazzola TN, Marba ST. Antenatal maternal corticosteroid administration and markers of oxidative stress and inflammation in umbilical cord blood from very low birth weight preterm newborn infants. J Pediatr (Rio J) 2012;88:61–66.
  • Chiba T, Omori A, Takahashi K, Tanaka K, Kudo K, Manabe M, Mariya Y, Kashiwakura I. Correlations between the detection of stress-associated hormone/oxidative stress markers in umbilical cord blood and the physical condition of the mother and neonate. J Obstet Gynaecol Res 2010;36:958–964.
  • Kimura C, Watanabe K, Iwasaki A, Mori T, Matsushita H, Shinohara K, Wakatsuki A. The severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restriction. J Matern Fetal Neonatal Med. 2012 Nov 8. [Epub ahead of print] (in press).
  • Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of “Ischemia modified albumin”, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29–34.
  • Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001;141:985–991.
  • Aoki S, Hata T, Manabe A, Miyazaki K. Decreased maternal circulating hepatocyte growth factor (HGF) concentrations in pregnancies with small for gestational age infants. Hum Reprod 1998;13:2950–2953.
  • Clark DE, Smith SK, Sharkey AM, Sowter HM, Charnock-Jones DS. Hepatocyte growth factor/scatter factor and its receptor c-met: localisation and expression in the human placenta throughout pregnancy. J Endocrinol 1996;151:459–467.
  • Rutherford SE, Phelan JP, Smith CV, Jacobs N. The four-quadrant assessment of amniotic fluid volume: an adjunct to antepartum fetal heart rate testing. Obstet Gynecol 1987;70:353–356.
  • Bar-Or D, Curtis G, Rao N, Bampos N, Lau E. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001;268:42–47.
  • Karahan SC, Koramaz I, Altun G, Uçar U, Topbas M, Mentese A, Kopuz M. Ischemia-modified albumin reduction after coronary bypass surgery is associated with the cardioprotective efficacy of cold-blood cardioplegia enriched with N-acetylcysteine: a preliminary study. Eur Surg Res 2010;44:30–36.
  • Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, et al.; Committee on Standardization of Markers of Cardiac Damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51:810–824.
  • Appasamy R, Tanabe M, Murase N, Zarnegar R, Venkataramanan R, Van Thiel DH, Michalopoulos GK. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab Invest 1993;68:270–276.
  • Yagi K. Lipid peroxides and related radicals in clinical medicine. Adv Exp Med Biol 1994;366:1–15.
  • Slatter DA, Paul RG, Murray M, Bailey AJ. Reactions of lipid-derived malondialdehyde with collagen. J Biol Chem 1999;274:19661–19669.
  • Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103–1111.
  • Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112–119.
  • Aycicek A, Erel O, Kocyigit A. Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers. Pediatr Int 2005;47:635–639.
  • Morrow RJ, Adamson SL, Bull SB, Ritchie JW. Effect of placental embolization on the umbilical arterial velocity waveform in fetal sheep. Am J Obstet Gynecol 1989;161:1055–1060.
  • Wilcox GR, Trudinger BJ, Cook CM, Wilcox WR, Connelly AJ. Reduced fetal platelet counts in pregnancies with abnormal Doppler umbilical flow waveforms. Obstet Gynecol 1989;73:639–643.
  • al-Ghazali W, Chita SK, Chapman MG, Allan LD. Evidence of redistribution of cardiac output in asymmetrical growth retardation. Br J Obstet Gynaecol 1989;96:697–704.
  • McCowan LM, Erskine LA, Ritchie K. Umbilical artery Doppler blood flow studies in the preterm, small for gestational age fetus. Am J Obstet Gynecol 1987;156:655–659.
  • Gudmundsson S, Marsal K. Umbilical and uteroplacental blood flow velocity waveforms in pregnancies with fetal growth retardation. Eur J Obstet Gynecol Reprod Biol 1988;27:187–196.
  • Baschat AA, Gembruch U, Reiss I, Gortner L, Weiner CP, Harman CR. Relationship between arterial and venous Doppler and perinatal outcome in fetal growth restriction. Ultrasound Obstet Gynecol 2000;16:407–413.
  • Gugliucci A, Hermo R, Monroy C, Numaguchi M, Kimura S. Ischemia-modified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveries. Clin Chim Acta 2005;362:155–160.
  • Iacovidou N, Briana DD, Boutsikou M, Liosi S, Baka S, Boutsikou T, Hassiakos D, Malamitsi-Puchner A. Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies. Mediators Inflamm 2008;2008:523081.
  • Baykal C, Güler G, Al A, Tulunay G, Ozer S, Yencilek R, Bülbül D, Ayhan A. Expression of hepatocyte growth factor/scatter factor receptor in IUGR fetuses’ placentas: an immunohistochemical analysis. Fetal Diagn Ther 2005;20:249–253.
  • Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, Gherardi E, Birchmeier C. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995;373:699–702.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.